Skip to Content

Diagnocure Inc DGCRF Stock Quote

| Rating as of

GREY:DGCRF

Morningstar‘s Stock Analysis DGCRF

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics DGCRF

Company Profile DGCRF

Business Description

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.

Contact
4535 Wilfrid-Hamel Boulevard, Suite 250
Quebec, QC, G1P 2J7, Canada
T +1 418 527-6100
Industry Biotechnology
Most Recent Earnings Jul 31, 2016
Fiscal Year End Oct 31, 2016
Employees 3